\[[PubMed: 34327881](https://pubmed.ncbi.nlm.nih.gov/34327881)\] 7. Rezkalla SH, Kloner RA. Viral myocarditis: 1917-2020: From the Influenza A to the COVID-19 pandemics. Trends Cardiovasc Med. 2021 Apr;31(3):163-169. \[[PMC free article: PMC7965406](/pmc/articles/PMC7965406/)\] \[[PubMed: 33383171](https://pubmed.ncbi.nlm.nih.gov/33383171)\] 8. Muchtar E, Blauwet LA, Gertz MA. Restrictive Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. Circ Res. 2017 Sep 15;121(7):819-837. \[[PubMed: 28912185](https://pubmed.ncbi.nlm.nih.gov/28912185)\] 9. Shams P, Ahmed I. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jul 30, 2023. Cardiac Amyloidosis. \[[PubMed: 35593829](https://pubmed.ncbi.nlm.nih.gov/35593829)\] 10. Brown KN, Pendela VS, Ahmed I, Diaz RR. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jul 30, 2023. Restrictive Cardiomyopathy. \[[PubMed: 30725919](https://pubmed.ncbi.nlm.nih.gov/30725919)\] 11. Matta AG, Carrié D. Epidemiology, Pathophysiology, Diagnosis, and Principles of Management of Takotsubo Cardiomyopathy: A Review. Med Sci Monit. 2023 Mar 06;29:e939020. \[[PMC free article: PMC9999670](/pmc/articles/PMC9999670/)\] \[[PubMed: 36872594](https://pubmed.ncbi.nlm.nih.gov/36872594)\] 12. Bairashevskaia AV, Belogubova SY, Kondratiuk MR, Rudnova DS, Sologova SS, Tereshkina OI, Avakyan EI. Update of Takotsubo cardiomyopathy: Present experience and outlook for the future. Int J Cardiol Heart Vasc. 2022 Apr;39:100990. \[[PMC free article: PMC8913320](/pmc/articles/PMC8913320/)\] \[[PubMed: 35281752](https://pubmed.ncbi.nlm.nih.gov/35281752)\] 13. Ahmad SA, Brito D, Khalid N, Ibrahim MA. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): May 22, 2023. Takotsubo Cardiomyopathy. \[[PubMed: 28613549](https://pubmed.ncbi.nlm.nih.gov/28613549)\] 14. DeFilippis EM, Beale A, Martyn T, Agarwal A, Elkayam U, Lam CSP, Hsich E. Heart Failure Subtypes and Cardiomyopathies in Women. Circ Res. 2022 Feb 18;130(4):436-454. \[[PMC free article: PMC10361647](/pmc/articles/PMC10361647/)\] \[[PubMed: 35175847](https://pubmed.ncbi.nlm.nih.gov/35175847)\] 15. Wong CM, Hawkins NM, Jhund PS, MacDonald MR, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, Petrie MC, McMurray JJ. Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity). J Am Coll Cardiol. 2013 Nov 12;62(20):1845-54. \[[PubMed: 23850914](https://pubmed.ncbi.nlm.nih.gov/23850914)\] 16. Sciomer S, Moscucci F, Salvioni E, Marchese G, Bussotti M, Corrà U, Piepoli MF. Role of gender, age and BMI in prognosis of heart failure. Eur J Prev Cardiol. 2020 Dec;27(2_suppl):46-51. \[[PMC free article: PMC7691623](/pmc/articles/PMC7691623/)\] \[[PubMed: 33238736](https://pubmed.ncbi.nlm.nih.gov/33238736)\] 17. Volpe M, Gallo G. Obesity and cardiovascular disease: An executive document on pathophysiological and clinical links promoted by the Italian Society of Cardiovascular Prevention (SIPREC). Front Cardiovasc Med. 2023;10:1136340. \[[PMC free article: PMC10040794](/pmc/articles/PMC10040794/)\] \[[PubMed: 36993998](https://pubmed.ncbi.nlm.nih.gov/36993998)\] 18. Kim DY, Kim SH, Ryu KH. Tachycardia induced Cardiomyopathy. Korean Circ J. 2019 Sep;49(9):808-817. \[[PMC free article: PMC6713829](/pmc/articles/PMC6713829/)\] \[[PubMed: 31456374](https://pubmed.ncbi.nlm.nih.gov/31456374)\] 19. Anakwue RC, Onwubere BJ, Anisiuba BC, Ikeh VO, Mbah A, Ike SO. Congestive heart failure in subjects with thyrotoxicosis in a black community. Vasc Health Risk Manag.